Drug Trial Radar · NCT06995001
Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: May 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
35
Actual
Start
Apr 28, 2024
Primary completion
Nov 28, 2024
Study completion Nov 28, 2024
Sponsor
- Lead sponsor
- Guangdong Hengrui Pharmaceutical Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- May 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics and immunogenicity of a single dose of SHR-2173 by subcutaneous injection.
Conditions
- Healthy Volunteers
Interventions
SHR-2173Drug
SHR-2173 injection dose 1;
SHR-2173 ;PlaceboDrug
SHR-2173 injection dose 2 ;Pacebo dose 2
SHR-2173 ;PlaceboDrug
SHR-2173 injection dose 3 ;Pacebo dose 3
SHR-2173 ;PlaceboDrug
SHR-2173 injection dose 4 ;Pacebo dose 4
SHR-2173 ;PlaceboDrug
SHR-2173 injection dose 5 ;Pacebo dose 5
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment-emergent Adverse Events (TEAE)Time frame: Day1~Day71
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Haikou People's Hospital
Haikou, Hainan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.